Single-center study finds similar risks for PGD-3 with both
In patients undergoing lung transplantation, risks for severe/grade 3 primary graft dysfunction (PGD-3) were similar whether patients were treated with inhaled epoprostenol (iEPO) or inhaled nitric oxide (iNO). Thus, researchers concluded, iEPO may be a viable option in the treatment of these patients.
They published their results in JAMA Surgery.
Inhaled nitric oxide (iNO) is administered after lung transplant (LT) to promote lung-allograft function by improving oxygenation and lowering pulmonary vascular resistance. Consequently, iNO may help mitigate development of severe (grade 3) primary graft dysfunction (PGD-3), which is diagnosed within 72 hours after LT and is strongly associated with short- and long-term mortality. Although iNO is not approved by the U.S. Food and Drug Administration for this indication, international guidelines support its use after LT, explained Kamrouz Ghadimi, MD, MHSc, of Duke University School of Medicine, Durham, North Carolina, and colleagues.
They added that iNO is roughly seven times more expensive than iEPO, and annual costs exceed millions of dollars nationwide, a disadvantage that has brought iEPO forward as a cost-saving alternative, despite a lack of robust evidence or comparisons with iNO.
In an interview with BreakingMED, Ghadimi explained the basis of their trial.
The study started out as a quality initiative in 2014-2015 at Duke University Hospital. We were charged with the question of evaluating our bottom-line use in the cardiothoracic ICUs regarding inhaled pulmonary vasodilator usage as an adjunct for the medical management of patients undergoing cardiothoracic surgery. Importantly, the patient service line that uses these medications most commonly in our cardiothoracic ICU are those who undergo lung transplantation as well as those that undergo advanced heart failure operations such as left ventricular assist devices or heart transplantation, he said.
We wanted to better evaluate these patients, if indeed we could utilize an alternative medication to the solitary inhaled vasodilator nitric oxide; if we could do this safely; if we could develop protocols; if all the stakeholders would be on board, including respiratory therapy, clinicians, other staff physicians surrounding the care of these patients were in agreement; and how we could best implement and deliver the medication, Ghadimi added.
In this independent analysis of patients from the Inhaled Selective Pulmonary Vasodilators for Advanced Heart Failure Therapies and Lung Transplantation Outcomes (INSPIRE-FLO) trial, Ghadimi and colleagues enrolled 201 patients (median age: 64 years; 64.2% men) with end-stage lung disease who underwent single (13.9%) or bilateral lung transplantation (86.1%). They grouped patients into five strata based on prognostic clinical features and then randomized patients per stratum to treatment with either iNO or iEPO at the time of lung transplantation.
The most common reason for lung transplantation was restrictive lung disease (62.7%), followed by obstructive disease (20.9%).
These are very vulnerable patients. They entrust our program, our clinicians, and our staff and coordinators. We didnt want to take this initiative lightly as we changed practice or implemented a new medication in this population, noted Ghadimi.
The median duration of time from randomization to treatment was five days, and the treatment durations were similar between the two treatment groups (45.7 hours in the iNO group versus 46.6 hours in the iEPO group), as were allogeneic packed red blood cell transfusion and ECMO support. Delayed chest closure occurred in 15.3% and 6.8%, respectively (P=0.530).
Treatment with both agents was initiated in the operating room before lung allograft reperfusion and administered continuously until cessation criteria met in the intensive care unit, explained Ghadimi et al. In the intention-to-treat population, 103 patients were treated with iEPO and 98 with iNO.
The primary outcomePGD-3 at 24, 48, or 72 hours after lung transplantationoccurred in 44.7% of patients treated with iEPO, compared with 39.8% of those treated with iNO (risk difference: 4.9%; TOST 90% CI: 6.4% to 16.2%: P=0.02 for equivalence). At 48 or 72 hours, these incidence rates were 28.2% and 26.5%, respectively (risk difference: 1.6%; 90% CI: 8.8% to 12.0% for equivalence); and at 72 hours, the rates were 16.3% versus 21.3% (risk difference: 5.0%; 90% CI: 4.5% to 14.6% for equivalence).Researchers found no between-group differences in secondary outcomes, which included duration of mechanical ventilation, hospital and ICU length of stay, incidence and severity of acute kidney injury, postoperative tracheostomy placement, and mortality rates in hospital and at 30 and 90 days.
In their accompanying editorial, Ankit Bharat, MD, of Northwestern University Feinberg School of Medicine, Chicago, and fellow editorialists wrote: The present study by Ghadimi et al lacks a control arm that did not receive any pulmonary vasodilators, allegedly owing to their institutional practices. Hence, it remains unclear whether either iNO or inhaled epoprostenol conferred any benefit and whether their use should be supported in routine prophylaxis against PGD. On the contrary, the seemingly higher rates of PGD might support that pulmonary vasodilators can paradoxically worsen allograft edema and increase PGD scores, they wrote.
Ghadimi explained that at Duke University, they now use iEPO as an alternative to iNO based on these results, but he offered an important caveat.
Other centers should consider the use of iEPO as an alternative to iNO based upon how they utilize the medications in their own centers. Thats important because how we utilize these medications might be different between centers, he told BreakingMED. At our center, we prophylactically put all patients on this medication. Other centers prefer to use the medication if its indicated, if theres a reason to suspect that there is a problem with the lung graft, and thats when they initiate it.
We use it in a certain way. I certainly encourage readers to look at our protocols (which are in the supplements) and take a deep dive and see how our approach fits in with theirs. I think theres a lot of opportunity here for multicenter collaborations, Ghadimi concluded.
Limitations of the study include its single-center design that was not placebo controlled, moderate size, and power, and short duration; the use of a prespecified equivalence margin based on an incidence range that may be too large; and the use of a stepwise, data-drive, model-building approach rather than a prespecified adjustment model due to the complexity of risk factors in these patients.
In this single-center study, researchers found that rates of severe/grade 3 primary graft dysfunction (PGD-3) after lung transplantation were similar between patients treated with inhaled epoprostenol (iEPO) or inhaled nitric oxide (iNO).
Be aware that this study investigated off-label use of both iEPO and iNO.
Liz Meszaros, Deputy Managing Editor, BreakingMED
This study was supported by the Duke University Health System.
Ghadimi reported receiving grant support from the National Institutes of Health, Duke Health, and the International Anesthesia Research SocietyMentored Research Training program.
Bharat reported no conflicts of interest.
Cat ID: 633
Topic ID: 630,633,570,633,730,192,195,925,159,312,492
Read more:
- Understanding Menopause and its Symptoms | Menopause Treatment Options - Medriva - December 28th, 2023 [December 28th, 2023]
- Breast cancer survivor Jayne Pritchard talks alternative therapies over tea - MidlandToday - December 28th, 2023 [December 28th, 2023]
- 12 unusual ways Israelis are volunteering during the war - ISRAEL21c - December 28th, 2023 [December 28th, 2023]
- Complementary and alternative medicine - NHS - December 26th, 2022 [December 26th, 2022]
- Alternative Treatment (CAM) for MS: Types, Side Effects & Cost - December 26th, 2022 [December 26th, 2022]
- Complementary and alternative medicine | History & Facts - December 26th, 2022 [December 26th, 2022]
- Alternative medicine: Definition, examples, benefits, and risks - October 28th, 2022 [October 28th, 2022]
- Alternative Medicine: The Science Behind 10 Alternative Therapies - October 21st, 2022 [October 21st, 2022]
- Detoxification (alternative medicine) - Wikipedia - October 21st, 2022 [October 21st, 2022]
- Alternative Approaches to Mental Health and Wellbeing - Psychiatric Times - October 19th, 2022 [October 19th, 2022]
- New practice focuses on dental sleep medicine, providing an alternative for patients who use CPAP machines - PennLive - October 19th, 2022 [October 19th, 2022]
- Dr. Deepak Chopra Aligns with Plant-Based Therapeutics Company ProVEDA to Highlight Topical Pain Relief Solutions - Yahoo Finance - October 19th, 2022 [October 19th, 2022]
- True REST Float Spa Offers Free Floatation Therapy Session to Veterans - AccessWire - October 19th, 2022 [October 19th, 2022]
- Youve been told you need surgery for degenerative disc disease and stenosis of the spine. Now what? - Sonoran News - October 19th, 2022 [October 19th, 2022]
- Can you take Paxlovid and heart disease medications at the same time? - Medical News Today - October 15th, 2022 [October 15th, 2022]
- Kardashian fans think theyve unlocked Kourtneys secret to hiding her pregnancy after spotting key detai... - The US Sun - October 15th, 2022 [October 15th, 2022]
- Cabinet approves B5bn for 'Andaman International Health Center' - The Phuket News - October 15th, 2022 [October 15th, 2022]
- Eye health and dynamics of the modern world - The Citizen - October 15th, 2022 [October 15th, 2022]
- The Holistic Review on Occurrence, Biology, Diagnosis, and Treatment of Oral Squamous Cell Carcinoma - Cureus - October 15th, 2022 [October 15th, 2022]
- 10 Deeper Causes of Tinnitus, and How to Treat It - The Epoch Times - October 15th, 2022 [October 15th, 2022]
- Complementary and Alternative Medicine (CAM) - GoodTherapy - October 13th, 2022 [October 13th, 2022]
- India's alternative medicine industry grows, boosted by COVID-19 pandemic - CNA - October 13th, 2022 [October 13th, 2022]
- QC Kinetix (Charlotte) Offers Alternative Treatments for Knee Pain and Sports Injuries - Yahoo Finance - October 13th, 2022 [October 13th, 2022]
- Plant Extracts Market is expected to generate a revenue of USD 85.09 Billion by 2030, Globally, at 6.33% CAGR: Verified Market Research - Yahoo... - October 13th, 2022 [October 13th, 2022]
- Neuroplasticity Nonsense Is Full of Red Flags - Science Based Medicine - October 13th, 2022 [October 13th, 2022]
- Diabetics won't be made to pay for alternative medicines, Pharmac says - Stuff - October 13th, 2022 [October 13th, 2022]
- Lili Reinhart Becomes A Reiki Master: My Journey Into Reiki Healing Cant Be Simplified - IMDb - October 13th, 2022 [October 13th, 2022]
- The DRIPBaR is Coming to Clarksville, TN on Oct 16, 2022 - PR Web - October 13th, 2022 [October 13th, 2022]
- How Dr. Oz Boosted an Osteopath Who Became a Top Spreader of Covid Misinformation Mother Jones - Mother Jones - October 13th, 2022 [October 13th, 2022]
- World Arthritis Day: Arthritis and Women - Times of India - October 13th, 2022 [October 13th, 2022]
- What Is Alternative Medicine? - American Cancer Society - October 6th, 2022 [October 6th, 2022]
- Herbal medicine: Types, uses, and safety - Medical News Today - October 6th, 2022 [October 6th, 2022]
- WCI Health LLC, Your Alternative Health and Wellness Hub Will Be a Vendor and Presenter at Wonderland Miami by Microdose - StreetInsider.com - October 6th, 2022 [October 6th, 2022]
- The Viral Real - Journal #130 October 2022 - E-Flux - October 6th, 2022 [October 6th, 2022]
- Pregabalin Market to Grow by USD 153.03 Mn from 2022 to 2026, Driven by Presence of Large Patient Pool Related To Neuropathic Pain - Technavio - Yahoo... - October 6th, 2022 [October 6th, 2022]
- Woman, 37, dies after herbal supplements led to liver failure: coroner - Insider - October 6th, 2022 [October 6th, 2022]
- What Is Vitiligo? All About This Unique Skin Condition That Impacts Skin Pigmentation, and How To Treat It - Parade Magazine - October 6th, 2022 [October 6th, 2022]
- Herbalist's Resource Guide to Cannabis and Other Plants That Can Prevent Cancer - PR Web - October 6th, 2022 [October 6th, 2022]
- Tasly Pharmaceuticals to Exhibit at BioJapan 2022 -- Bio-Pharmaceutical Company to Join with Maryland-Bas - Benzinga - October 6th, 2022 [October 6th, 2022]
- "Sh*t, I just want to get better. Thats what pushed me to do it, and it worked well" Chauncey Billups and other NBA stars on acupuncture -... - October 6th, 2022 [October 6th, 2022]
- People Science and Symbiome Partner to study the microbiome in the real world - Benzinga - October 6th, 2022 [October 6th, 2022]
- Bob Newhart Proves 93 Is the New 39 - Eat This, Not That - September 29th, 2022 [September 29th, 2022]
- Medical cannabis could be better alternative to opioids in managing pain - The Tribune India - September 29th, 2022 [September 29th, 2022]
- Woman killed by herbal remedies she took to treat arthritis - Evening Standard - September 29th, 2022 [September 29th, 2022]
- Get To Know The Best Natural Adderall Alternatives - Over The Counter and Non Prescription - Outlook India - September 29th, 2022 [September 29th, 2022]
- King Charles III Has a History of Promoting 'Quackery' Alternative Medicine - Newsweek - September 9th, 2022 [September 9th, 2022]
- Remedy Place: The Fashionable Social Wellness Club Where You Can Bring All Your Friends - Vogue - September 9th, 2022 [September 9th, 2022]
- Thailand heightens its healthcare hub ambition with integrative medicine - PR Newswire UK - September 9th, 2022 [September 9th, 2022]
- How bogus cancer treatments prey on the most vulnerable - Coda Story - September 9th, 2022 [September 9th, 2022]
- Management of Chronic Migraine in Children and Adolescents | PHMT - Dove Medical Press - September 9th, 2022 [September 9th, 2022]
- Mouth Taping: Is It Safe? - Health Essentials - September 9th, 2022 [September 9th, 2022]
- Queen Elizabeth: Seven things you need to know about the Queens passing - Toronto Star - September 9th, 2022 [September 9th, 2022]
- Building an Alternative Medical Economy in Response to 'Tyranny': Telehealth CEO - The Epoch Times - August 30th, 2022 [August 30th, 2022]
- Sesame oil: Nutrition, benefits, and more - Medical News Today - August 30th, 2022 [August 30th, 2022]
- Regenerative Medicine: An alternative to surgery and pills | Loop Cayman Islands - Loop News Cayman - August 30th, 2022 [August 30th, 2022]
- Find Euphoria: the luxury Greek spa retreat to visit now - Tatler - August 30th, 2022 [August 30th, 2022]
- What Is Synthetic Urine & How Does It Help To Pass A Drug Test? - The Island Now - August 30th, 2022 [August 30th, 2022]
- The science behind the healthtech startup must be understood well - Express Healthcare - August 30th, 2022 [August 30th, 2022]
- Best-in-class second-line HIV treatment rolls out in Zambia and Nigeria - Clinton Health Access Initiative - August 30th, 2022 [August 30th, 2022]
- Therapeutic effect of HFNC and NIV in patients with AECOPD | COPD - Dove Medical Press - August 30th, 2022 [August 30th, 2022]
- Five years after Kymriah: Ensuring the next cell and gene therapies reach patients - STAT - August 30th, 2022 [August 30th, 2022]
- Meet these renowned healthcare professionals who assist us in leading healthier lives - Oneindia - August 30th, 2022 [August 30th, 2022]
- Diet and Vitiligo: The Story So Far - Cureus - August 29th, 2022 [August 29th, 2022]
- Fatphobia Sucks, Especially If You're Trying to Have a Baby - VICE - August 29th, 2022 [August 29th, 2022]
- Orthomolecular Medicine, A Predictive Tool - Nation World News - August 29th, 2022 [August 29th, 2022]
- COVID-19 vaccines and the Nuremberg Code - Science Based Medicine - August 29th, 2022 [August 29th, 2022]
- Bolstering the Blood-CNS Barrier Could Lead to New Treatment Approach for Multiple Sclerosis - University of Utah Health Care - August 29th, 2022 [August 29th, 2022]
- Lockdowns Postponed the Inevitable. Is That a Bad Thing? - Science Based Medicine - August 29th, 2022 [August 29th, 2022]
- The Impact of Complementary and Alternative Medicine on Insomnia: A Systematic Review - Cureus - August 27th, 2022 [August 27th, 2022]
- Ayurveda As Alternative Medicine: Research And Development To Be Taken Ahead By Heal In India - Entrepreneur - August 27th, 2022 [August 27th, 2022]
- French Doctolib platform accused of 'promoting alternative medicine' - The Connexion - August 27th, 2022 [August 27th, 2022]
- Chronic Fatigue Syndrome: Best Ways for Treating This Condition - Healthline - August 27th, 2022 [August 27th, 2022]
- Ellen White reveals "traumatic" incident that played huge role in her retirement - GIVEMESPORT - August 27th, 2022 [August 27th, 2022]
- Curcumin and Non-Hodgkin's Lymphoma: Does It Help? - Healthline - August 27th, 2022 [August 27th, 2022]
- In Denial: When Patients Don't Want to Believe They Have Cancer - Medscape - August 27th, 2022 [August 27th, 2022]
- Piotr Szyhalski depicts living through COVID-19 and other extreme historical phenomena - MinnPost - August 27th, 2022 [August 27th, 2022]
- Researchers identify chemo alternative for targeted treatment of leukemia patients - Devdiscourse - August 27th, 2022 [August 27th, 2022]
- India Can Show The World The Right Path For Medical Pluralism - News18 - August 27th, 2022 [August 27th, 2022]
- Complementary and Integrative Medicine - Reeve Foundation - Christopher Reeve Foundation - August 23rd, 2022 [August 23rd, 2022]
- Back pain: Exploring alternative treatments - Health - Life & Style - Ahram Online - August 23rd, 2022 [August 23rd, 2022]